P. Kelly Marcom, MD | Authors

2 WRAMC DEPARTMENT

6900 GEORGIA AVE. NW

Articles

HER2-Positive Breast Cancer: Remaining Challenges

December 01, 2006

In their article, "Trastuzumab and Beyond: New Possibilities for the Treatment of HER2-Positive Breast Cancer," Drs. Morris and Carey provide an excellent summary of therapeutic progress in this disease, and also turn their attention to the challenge now facing us--that of understanding the heterogeneity of HER2-positive breast cancer and mechanisms of resistance to trastuzumab (Herceptin)-based therapy.